PH22108A - Dna encoding human tumor necrosis factor and human tumor necrosis factor polypeptide - Google Patents

Dna encoding human tumor necrosis factor and human tumor necrosis factor polypeptide

Info

Publication number
PH22108A
PH22108A PH31937A PH31937A PH22108A PH 22108 A PH22108 A PH 22108A PH 31937 A PH31937 A PH 31937A PH 31937 A PH31937 A PH 31937A PH 22108 A PH22108 A PH 22108A
Authority
PH
Philippines
Prior art keywords
necrosis factor
tumor necrosis
human tumor
dna encoding
polypeptide
Prior art date
Application number
PH31937A
Other languages
English (en)
Inventor
Yasuji Furutani
Mitsue Notake
Juniti Yamagishi
Masaaki Yamada
Original Assignee
Dainippon Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP59043617A external-priority patent/JPS60185799A/ja
Priority claimed from JP59082653A external-priority patent/JPS60232097A/ja
Priority claimed from JP59172307A external-priority patent/JP2584206B2/ja
Application filed by Dainippon Pharmaceutical Co filed Critical Dainippon Pharmaceutical Co
Publication of PH22108A publication Critical patent/PH22108A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/034—Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the periplasmic space of Gram negative bacteria as a soluble protein, i.e. signal sequence should be cleaved
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PH31937A 1984-03-06 1985-03-04 Dna encoding human tumor necrosis factor and human tumor necrosis factor polypeptide PH22108A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP59043617A JPS60185799A (ja) 1984-03-06 1984-03-06 ヒト癌壊死因子
JP59082653A JPS60232097A (ja) 1984-04-23 1984-04-23 ヒト癌壊死因子ポリペプチドの製造法
JP59172307A JP2584206B2 (ja) 1984-08-17 1984-08-17 ヒト癌壊死因子

Publications (1)

Publication Number Publication Date
PH22108A true PH22108A (en) 1988-06-01

Family

ID=27291610

Family Applications (1)

Application Number Title Priority Date Filing Date
PH31937A PH22108A (en) 1984-03-06 1985-03-04 Dna encoding human tumor necrosis factor and human tumor necrosis factor polypeptide

Country Status (11)

Country Link
EP (1) EP0155549B1 (fr)
KR (1) KR920010225B1 (fr)
AU (1) AU584608B2 (fr)
CA (1) CA1341240C (fr)
DE (2) DE3582183D1 (fr)
DK (1) DK172013B1 (fr)
ES (2) ES8802159A1 (fr)
FR (1) FR99C0037I2 (fr)
HU (1) HU202921B (fr)
NL (1) NL990034I2 (fr)
PH (1) PH22108A (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60112718A (ja) * 1983-11-21 1985-06-19 Kyorin Pharmaceut Co Ltd 抗腫瘍作用を示す蛋白性物質及びその製造方法
JPH0695939B2 (ja) * 1983-12-02 1994-11-30 大日本製薬株式会社 ウサギ癌壊死因子をコ−ドするクロ−ン化ｄνａ
US4879226A (en) * 1984-04-06 1989-11-07 Asahi Kasei Kogyo Kabushiki Kaisha Novel human physiologically active polypeptide
GR851626B (fr) * 1984-07-05 1985-11-26 Genentech Inc
US5672347A (en) * 1984-07-05 1997-09-30 Genentech, Inc. Tumor necrosis factor antagonists and their use
US6686455B1 (en) 1984-07-05 2004-02-03 Genentech, Inc. Tumor necrosis factor
WO1986002381A1 (fr) * 1984-10-15 1986-04-24 Cetus Corporation Facteur de necrose de tumeurs humaines
US4959314A (en) 1984-11-09 1990-09-25 Cetus Corporation Cysteine-depleted muteins of biologically active proteins
EP0216786B1 (fr) * 1984-12-21 1992-03-18 Biogen, Inc. Purification, production et utilisation de facteurs necrotiques tumoraux
JPS6248634A (ja) * 1985-07-23 1987-03-03 Mochida Pharmaceut Co Ltd 新規アミノ酸組成物、その製造方法及び該アミノ酸組成物を含有する医療組成物
JPH064675B2 (ja) * 1985-07-29 1994-01-19 伝一 水野 抗腫瘍性ポリペプチド
JPH0698004B2 (ja) * 1985-09-30 1994-12-07 サントリー株式会社 Ｔｎｆ発現用新規プラスミド
US5059530A (en) * 1985-09-30 1991-10-22 Suntory Ltd. Expression vector for human TNF
CA1286843C (fr) * 1985-10-30 1991-07-23 Leo S. Lin Methode d'epuration de proteines
US4894439A (en) * 1986-05-22 1990-01-16 Cetus Corporation N-terminal derivatives of tumor necrosis factor purified by microporous PTFE membranes
US4677197A (en) * 1985-10-30 1987-06-30 Cetus Corporation Purification method for tumor necrosis factor
EP0247906B1 (fr) * 1986-02-04 1994-12-28 Mizuno, Den'Ichi ADN codant pour des polypeptides antitumoraux, les polypeptides et les agents antitumoraux contenant ces polypeptides
KR940005589B1 (ko) * 1986-04-02 1994-06-21 다이닛뽄세이야꾸 가부시끼가이샤 핵산 또는 엔도톡신의 제거제 및 제거방법
US5425940A (en) * 1986-04-09 1995-06-20 Cetus Oncology Corporation Combination therapy using interleukin-2 and tumor necrosis factor
DE3750056T2 (de) * 1986-06-20 1995-04-06 Dainippon Pharmaceutical Co Polypeptid-Mutanten des menschlichen TNF und für diese Mutanten codierende DNS.
WO1988006625A2 (fr) * 1987-02-26 1988-09-07 Cetus Corporation Facteur de necrose tumorale humaine appauvri en arginine
DE3716513A1 (de) * 1987-05-16 1988-11-24 Basf Ag Proteine mit tnf-wirkung
JP2828988B2 (ja) * 1988-04-03 1998-11-25 源一郎 杣 新規ｄｎａとその生産方法、それを有する新規プラスミド、新規ポリペプチドとその生産方法、及び該ポリペプチドからなる新規抗腫瘍剤
GB2217325B (en) * 1988-04-08 1991-11-20 British Bio Technology Synthetic gene for tumour necrosis factor alpha.
JPH0797997B2 (ja) * 1988-04-28 1995-10-25 帝人株式会社 新規生理活性ポリペプチド
DE3843534A1 (de) * 1988-12-23 1990-07-12 Basf Ag Neue tnf-polypeptide
US6586222B1 (en) 1989-08-16 2003-07-01 Chiron Corporation Recombinant PR-3 and compositions thereof
JP2930713B2 (ja) 1989-08-16 1999-08-03 カイロン コーポレイション タンパク質ホルモン形成の抑制用の組成物およびその使用法
US5998378A (en) * 1989-08-16 1999-12-07 Chiron Corporation Compositions for the inhibition of TNF hormone formation and uses thereof
US5843693A (en) * 1989-08-16 1998-12-01 Chiron Corporation Assay method for screening for inhibitors of proTNF conversion
WO1991017180A1 (fr) * 1990-04-27 1991-11-14 Peptide Technology Ltd Peptides derives du facteur de necrose tumorale humain alpha utiles contre les parasites paludeens intracellulaires
KR970005042B1 (ko) * 1993-02-09 1997-04-11 한일합성섬유공업 주식회사 종양괴사인자-알파 뮤테인
CA2119089A1 (fr) * 1993-03-29 1994-09-30 David Banner Muteines du facteur de necrose tumoral
CA2185162A1 (fr) 1994-03-07 1995-09-14 Robert F. Halenback (Deceased) Compositions pour inhiber la formation de tnf et leur emploi
US6395273B1 (en) 1998-06-10 2002-05-28 Promega Corporation Prevention and treatment of inflammatory bowel disease
ES2151403B1 (es) * 1998-07-13 2001-07-01 Hernandez Bronchud Miguel Linea celular transformada de rata productora de tnf-alfa humano recombinante.
US20030086903A1 (en) 2001-11-02 2003-05-08 Genvec, Inc. Therapeutic regimen for treating cancer
EP3936137A1 (fr) 2013-02-07 2022-01-12 The General Hospital Corporation Procédés d'expansion ou de déplétion de lymphocytes t régulateurs
US11312922B2 (en) 2019-04-12 2022-04-26 Ecolab Usa Inc. Antimicrobial multi-purpose cleaner comprising a sulfonic acid-containing surfactant and methods of making and using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879226A (en) * 1984-04-06 1989-11-07 Asahi Kasei Kogyo Kabushiki Kaisha Novel human physiologically active polypeptide
JPS60260522A (ja) * 1984-06-07 1985-12-23 Asahi Chem Ind Co Ltd 遺伝子組換体が生産する生理活性物質の安定化法
GR851626B (fr) * 1984-07-05 1985-11-26 Genentech Inc
WO1986002381A1 (fr) * 1984-10-15 1986-04-24 Cetus Corporation Facteur de necrose de tumeurs humaines
JPS61124392A (ja) * 1984-11-22 1986-06-12 Asahi Chem Ind Co Ltd 遺伝子組換体の産生する生理活性物質の精製法

Also Published As

Publication number Publication date
EP0155549A2 (fr) 1985-09-25
AU584608B2 (en) 1989-06-01
KR920010225B1 (ko) 1992-11-21
ES540939A0 (es) 1988-04-01
HUT37957A (en) 1986-03-28
ES8802159A1 (es) 1988-04-01
NL990034I1 (nl) 1999-12-01
DK172013B1 (da) 1997-09-15
ES8703490A1 (es) 1987-02-16
DK100985D0 (da) 1985-03-05
DE19975063I2 (de) 2005-08-18
AU3944885A (en) 1985-09-12
FR99C0037I1 (fr) 1999-12-10
DK100985A (da) 1985-09-07
EP0155549B1 (fr) 1991-03-20
NL990034I2 (nl) 2000-11-01
EP0155549A3 (en) 1986-12-30
ES550939A0 (es) 1987-02-16
FR99C0037I2 (fr) 2000-10-27
HU202921B (en) 1991-04-29
KR850006874A (ko) 1985-10-21
DE19975063I1 (de) 2005-07-14
DE3582183D1 (de) 1991-04-25
CA1341240C (fr) 2001-06-05

Similar Documents

Publication Publication Date Title
PH22108A (en) Dna encoding human tumor necrosis factor and human tumor necrosis factor polypeptide
GB2158829B (en) Human tumor necrosis factor and dna therefor
EP0183350A3 (en) Dna endcoding human colony stimulating factor, peptide encoded thereby,vectors and transformed hosts containing such dna, and the production of all thereof
GB8819209D0 (en) Polypeptide & dna encoding same
PT78773A (en) The effect of human tumor necrosis factor and human interferon on human cancer cells and methods
EP0162699A3 (en) Interleukin-2 receptor and dna encoded therefor and their preparation
AU5010685A (en) Human tumor necrosis factor
EP0161901A3 (en) Human il-1 cdna sequences encoding biologically-active human il-1 proteins
IL83930A0 (en) Purification of recombinant tumor necrosis factor
GB2164044B (en) -hanp related polypeptides and their use
EP0195592A3 (en) Factor ix protein
EP0164273A3 (en) New peptide and gene coding for same
ZA862479B (en) Recombinant human renin
ZA857906B (en) Human tumor necrosis factor
GB8929110D0 (en) Polypeptides and dna encoding therefor
GR890100185A (en) Novel polypeptides having growth factor activity and nucleic acid sequences encoding the polypeptides
EP0286114A3 (en) Reg gene and protein encoded by the gene
PH24603A (en) Novel polypeptides having growth factor activity and nucleic acid sequences encoding the polypeptides
IL74094A0 (en) Highly solubilised protein and production thereof
EP0378676A4 (en) Tumor necrosis enhancing factor and methods of preparation and use
ZA9010036B (en) Expression of the recombinant tumor necrosis factor binding protein i(tbp-i)
ZA854295B (en) New peptide and gene coding for same
ATE61817T1 (de) Dns den menschlichen tumornekrosisfaktor kodierend und das menschliche tumornekronisfaktor-polypeptid.
ZA855059B (en) Tumor necrosis factor
HRP950156B1 (en) Tumor necrosis factor